Answers are grounded in this paper and cite their sources.
The currently available methodological evidence points towards a high quality of the AMS scale to measure and to compare HRQoL of aging males over time or before/after treatment, it suggests a high reliability and high validity as far as the process of construct validation could be pressed ahead yet. But certainly more data will become available, particularly from ongoing clinical studies.
No takes yet. Share an insight, caveat, or question.
Daig et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: